Karin Förster
Impact in
-
- Osteoarthritis Treatment and Mechanisms
Papers in
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 4
- Respiratory Support and Mechanisms 1
- Inhalation and Respiratory Drug Delivery 1
-
- Asthma and respiratory diseases 3
- Co-authors
- Lucio C. Rovati (1 shared paper)Michael J. M. Fischer (1 shared paper)A. Reichelt (1 shared paper)I Setnikar (1 shared paper)Beatrix Bálint (2 shared papers)Anneliese Linnhoff (2 shared papers)Henrik Watz (2 shared papers)Marie Cullberg (2 shared papers)
- Journals
- Respiratory Medicine (1 paper)Pulmonary Pharmacology & Therapeutics (1 paper)PubMed (1 paper)
In The Last Decade
Karin Förster
4 papers receiving 164 citations
Peers
Comparison fields: 5 of 51
- Rheumatology 49
- Equine 5
- Pharmacology 39
- Immunology 44
- Pulmonary and Respiratory Medicine 66
Countries citing papers authored by Karin Förster
This map shows the geographic impact of Karin Förster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Förster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Förster more than expected).
Fields of papers citing papers by Karin Förster
This network shows the impact of papers produced by Karin Förster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Förster. The network helps show where Karin Förster may publish in the future.
Co-authors
The 23 scholars most cited alongside Karin Förster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 73 | |
| 2 | Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee. A randomised, placebo-controlled, double-blind study. | 1994 | 66 |
| 3 | 2010 | 35 | |
| 4 | The safety and tolerability of twice-daily oral doses of AZD5069, a novel CXCR2 antagonist, in patients with moderate-to-severe COPD | 2012 | 3 |
| 5 | Once-daily QVA149 improves lung function and dyspnoea compared with tiotropium plus formoterol: The QUANTIFY study | 2014 | 1 |
About Karin Förster
Karin Förster is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Organic Chemistry, Pharmacology and Epidemiology, having authored 5 papers that have together received 178 indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Asthma and respiratory diseases (3 papers), Synthesis and Reactivity of Sulfur-Containing Compounds (1 paper), Inflammation biomarkers and pathways (1 paper), Osteoarthritis Treatment and Mechanisms (1 paper), Cardiovascular and exercise physiology (1 paper), Respiratory Support and Mechanisms (1 paper) and Inhalation and Respiratory Drug Delivery (1 paper). The work is most often cited by research in Rheumatology (49 citations), Equine (5 citations), Pharmacology (39 citations), Immunology (44 citations) and Pulmonary and Respiratory Medicine (66 citations). Karin Förster has collaborated with scholars based in Germany, Sweden and Estonia. Frequent co-authors include Lucio C. Rovati, Michael J. M. Fischer, A. Reichelt, I Setnikar, Beatrix Bálint, Anneliese Linnhoff, Henrik Watz, Marie Cullberg, Heather Wray and B. Larsson. Their work appears in journals such as Respiratory Medicine, Pulmonary Pharmacology & Therapeutics and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.